Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CWBC
5051
Community West Bancshares
CWBC
$708M
| $125K | ﹤0.01% |
8,059
+1,601
| +25% | +$24.8K |
|
5052
Vaalco Energy
EGY
$608M
| $125K | ﹤0.01% |
33,499
+933
| +3% | +$3.81K |
|
5053
Geron
GERN
$943M
| $125K | ﹤0.01% |
38,836
+9,325
| +32% | +$26.5K |
|
5054
Medallion Financial
MFIN
$264M
| $125K | ﹤0.01% |
15,790
+1,958
| +14% | +$13.4K |
|
5055
Procept Biorobotics
PRCT
$1.24B
| $125K | ﹤0.01% |
3,550
+1,281
| +56% | +$42.4K |
|
5056
Protolabs
PRLB
$2.2B
| $125K | ﹤0.01% |
3,575
+599
| +20% | +$19.1K |
|
|
RGT
5057
Royce Global Value Trust
RGT
$101M
| $125K | ﹤0.01% |
13,519
-8,794
| -39% | -$78K |
|
|
ZUO
5058
DELISTED
Zuora, Inc.
ZUO
| $125K | ﹤0.01% |
11,469
-22,528
| -66% | -$213K |
|
|
DICE
5059
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $125K | ﹤0.01% |
2,695
+703
| +35% | +$24.3K |
|
5060
Apogee Enterprises
APOG
$889M
| $124K | ﹤0.01% |
2,595
+635
| +32% | +$26.5K |
|
5061
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
$9.35B
| $124K | ﹤0.01% |
+5,141
| New | +$122K |
|
5062
Strive US Semiconductor ETF
SHOC
$245M
| $124K | ﹤0.01% |
+3,583
| New | +$111K |
|
|
AFCG
5063
AFC Gamma
AFCG
$72.1M
| $123K | ﹤0.01% |
14,511
+1,150
| +9% | +$9.32K |
|
5064
ARK Space & Defense Innovation ETF
ARKX
$865M
| $123K | ﹤0.01% |
8,115
-19,573
| -71% | -$272K |
|
5065
Astronics
ATRO
$4.61B
| $123K | ﹤0.01% |
7,409
+792
| +12% | +$10.8K |
|
5066
Aurora
AUR
$13.7B
| $123K | ﹤0.01% |
41,942
+34,893
| +495% | +$58.4K |
|
5067
Helix Energy Solutions
HLX
$1.54B
| $123K | ﹤0.01% |
16,686
+7,104
| +74% | +$50.5K |
|
5068
PUT
MongoDB
MDB
$37B
| $123K | ﹤0.01% |
300
| – | – |
|
|
MQT
5069
DELISTED
BlackRock MuniYield Quality Fund II
MQT
| $123K | ﹤0.01% |
12,270
-4,165
| -25% | -$42.1K |
|
|
NCZ
5070
Virtus Convertible & Income Fund II
NCZ
$308M
| $123K | ﹤0.01% |
9,904
-61
| -0.6% | -$724 |
|
5071
Global X Nasdaq 100 Covered Call & Growth ETF
QYLG
$168M
| $123K | ﹤0.01% |
4,460
+708
| +19% | +$18.5K |
|
5072
Vista Energy
VIST
$7.56B
| $123K | ﹤0.01% |
5,078
+4,313
| +564% | +$93.8K |
|
|
PTRS
5073
DELISTED
Partners Bancorp Common Stock
PTRS
| $123K | ﹤0.01% |
19,764
+207
| +1% | +$1.35K |
|
|
AAT
5074
American Assets Trust
AAT
$1.4B
| $122K | ﹤0.01% |
6,344
-91,549
| -94% | -$1.72M |
|
5075
iShares BB Rated Corporate Bond ETF
HYBB
$429M
| $122K | ﹤0.01% |
+2,729
| New | +$122K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.